20th Annual Biotech in Europe Forum

Published on 23 September 2020
Sachs 20th Annual Biotech in Europe Forum feature image 08042020

About the Biotech in Europe Forum

Sachs Associates will be hosting its 20th Annual Biotech in Europe Forum (BEF) on 23–24 September 2020. The forum is the leading international stage for those interested in investing and partnering in the biotech and life science industry. This highly transactional event brings together an exciting cross-section of early-stage/pre-IPO, late-stage and public companies with leading investors, analysts, money managers and pharma licensing executives. Supported and designed by leading figures in Europe’s pharmaceutical and biotech industry, this event will once again be covered by our regular media partners. We expect more than 700 delegates and over 80 presenting companies, and 30+ pitches by seed companies.

Reserve your place here

Plenary sessions will include:

  • Early-stage partnering and investment panel.
  • Global partnering panel.
  • Global venture capital and private equity roundtable.
  • Partnering with Chinese pharma and biotech companies panel.
  • Regional panel.
  • Public markets and IPOs panel.
  • Rising stars: Global seed session.
  • State of the industry review panel.

Therapeutic panels will include:

  • Advanced neuroscience – science and deal-making panel.
  • Autoimmune and inflammatory diseases panel.
  • Biome and nutrition panel.
  • Gene and cell therapy panel.
  • Oncology I – advanced therapeutics and diagnostics panel.
  • Oncology II – business development and licensing panel.
  • Platform technologies and novel therapeutics panel.
  • Vaccines and infectious diseases panel.



The BEF forum will be held for the seventh time in Basel to be close to the largest biopharma hub in Europe and the Congress Center provides space capable of handling several thousand one-to-one meetings, as well as significant exhibition space. The programme will feature a number of plenary panels covering business development and licensing in the main therapeutic areas.

The forum will provide a number of networking opportunities via our online one-to-one meeting system, which allows you to pre-book meetings with all the attendees with dedicated meeting facilities. We expect more than 3,000 meetings to take place over the two days.

Presenting opportunities

European-HealthTech-CEO-Forum-exhibition image​Presenting at the forum offers excellent opportunities to showcase your company to some of the leading global investors and corporates. It gives you the chance to communicate your projected capital-raising plans or simply help you to find the right partner for your business. Presenting companies from Europe and the US will benefit from specially designed panels and keynote addresses from leading industry figures, as well as access to some of the leading analysts and investors from Europe and beyond. This year, Sachs aims to expand the audience and once again provide opportunities for executive-level networking, deal-making and strategic partnering.

Exhibiting opportunities

Make connections, engage in conversation and exchange knowledge with key decision-makers eager to learn how your company can help them meet their goals and achieve their mission. Exhibiting at the 20th Annual Biotech in Europe Forum is an effective way to gain leads, introduce new products and services, expand sales and build relationships.​

Summary

Event: 20th Annual Biotech in Europe Forum
Date: 23–24 September 2020
Location: Congress Center Basel, Switzerland
Hosted by: Sachs Associates
About: Sachs Associates will host its 20th Annual Biotech in Europe Forum (BEF) on 23–24 September 2020. The forum is recognised as the leading international stage for those interested in investing and partnering in the biotech and life science industry. This highly transactional event brings together an exciting cross-section of early-stage/pre-IPO, late-stage and public companies with leading investors, analysts, money managers and pharma licensing executives. Supported and designed by leading figures in Europe’s pharmaceutical and biotech industry, this event will once again be covered by our regular media partners. We expect more than 700 delegates and over 80 presenting companies, and 30+ pitches by seed companies.

For more information or to register your interest, contact the Sachs team on SachsTeam@sachsforum.com.

Share this with friends and colleagues